Photobiomodulation (PBM), evaluated in this study, will be delivered by a CE marked class IIa medical device (MILTA technology), composed of a panel that gathers 18 emitters. This is an innovative, alternative, soft technology, based on a cross action of LED light emission, a low intensity nanopulsed laser and a magnetic tunnel. The sessions last 10 minutes each, in total in the study two sessions will be delivered.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Evaluation of the effectiveness of photobiomodulation (PBM) on pain in immediate postpartum patients
Timeframe: 30 minutes after first PBM session for the experimental and control 1 groups
Evaluation of the effectiveness of photobiomodulation on pain in immediate postpartum patients
Timeframe: 30 minutes after first PBM session for the experimental group or 30 minutes after analgesic treatment for the group control 2